Addex Therapeutics Ltd
ADDXF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$173.12M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $173.12 Million |
|---|---|
| Enterprise Value | $172.43 Million |
| Earnings per Share | $-0.15 |
| Beta | 1.52 |
| Outstanding Shares | 174,868,000 |
Return
| Return on Equity | -358.96% |
|---|---|
| Return on Assets | -196.79% |
| Return on Invested Capital | -216.30% |
Valuation & Multiples
| P/E Ratio | -0.48 |
|---|---|
| PEG | 8.61 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 907.54 |
| Enterprise Value to EBIT | -37.67 |
| Enterprise Value to Net Income | -26 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Addex Therapeutics Ltd
27 employees
CEO: Tim Dyer
Addex Therapeutics Ltd is a biopharmaceutical firm based in Switzerland, dedicated to identifying, developing, and commercializing small-molecule pharmaceutical products designed to address central nervous system (CNS) disorders. The com...